Int J Med Sci:中国200余万高血压门诊患者合并症分析:华北地区合并高血脂症和冠心病者比例高

2017-04-05 卢芳 中国循环杂志

近期,一项由中美学者在全国29家医院200多万高血压患者中进行的研究显示,18%合并糖尿病,9.2%合并高脂血症,14.1%合并冠心病。研究显示,与女性高血压患者相比,男性高血压伴糖尿病的风险增加6%,伴血脂异常的风险增加13%,伴冠心病的风险增17%。此外,值得注意的是,45~59岁的中年高血压人群血脂异常患病率明显要高于<44岁和≥60岁者。口袋里的钱,也会影响高血压及其合并症的流行。研究显示

近期,一项由中美学者在全国29家医院200多万高血压患者中进行的研究显示,18%合并糖尿病,9.2%合并高脂血症,14.1%合并冠心病。

研究显示,与女性高血压患者相比,男性高血压伴糖尿病的风险增加6%,伴血脂异常的风险增加13%,伴冠心病的风险增17%。

此外,值得注意的是,45~59岁的中年高血压人群血脂异常患病率明显要高于<44岁和≥60岁者。

口袋里的钱,也会影响高血压及其合并症的流行。研究显示,高收入人群占整个高血压人群的68.24%,还有七成伴有糖尿病,77.39%血脂异常,57.32%合并冠心病。

不过,相比与低收入高血压人群,高收入高血压患者冠心病罹患率偏低;伴发糖尿病情况不受收入影响。而合并血脂异常风险要高出2倍左右。

研究者推测,中年人以及高收入高血压人群由于工作原因,多活动少、聚餐多,从而血脂异常较为多见。其中,高收入人群冠心病患病率低,或是由于比低收入人群看病早干预早的缘故。

研究还显示,那些有糖尿病和冠心病的高血压患者多更倾向于去三甲医院就诊。

从地理区域来看,在总的高血压伴糖尿病患者中,华东地区比例最高占35.29%;而在总的高血压合并高血脂者中,华北地区占比最高为69.82%,此外,合并冠心病高血压患者中,华北占比也为首,达40.16%。

图1  全国29个城市29家医院高血压患者合并症流行状况

进一步分析显示,华南和华北高血压患者血脂异常风险更高;华南和华东高血压患者冠心病风险更高。

研究者认为,经济效力在其中起到一定影响作用,快速发展的经济同时也会激发高脂饮食、不健康生活方式和更大压力的流行。

该研究的数据来自2011-01至2013-12期间,全国29个城市29家医院的电子病历,包括2,122,703位高血压门诊患者。其中高低收入的定义为,是否高于全国人均收入水平。

原始出处:

Wang J, Ma JJ, Liu J, et al. Prevalence and Risk Factors of Comorbidities among Hypertensive Patients in China. Int J Med Sci. 2017, 14.

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1932037, encodeId=0b4a193203ea1, content=<a href='/topic/show?id=e7bd9e12736' target=_blank style='color:#2F92EE;'>#门诊患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97127, encryptionId=e7bd9e12736, topicName=门诊患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b191324, createdName=marongnuan, createdTime=Tue Jul 04 20:58:00 CST 2017, time=2017-07-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1825829, encodeId=109f182582942, content=<a href='/topic/show?id=c52d388137b' target=_blank style='color:#2F92EE;'>#合并症#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=38813, encryptionId=c52d388137b, topicName=合并症)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=796422, createdName=lvliquan, createdTime=Sun Nov 05 15:58:00 CST 2017, time=2017-11-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1665196, encodeId=2bd9166519644, content=<a href='/topic/show?id=bcb5102e37cf' target=_blank style='color:#2F92EE;'>#高血脂症#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=102737, encryptionId=bcb5102e37cf, topicName=高血脂症)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=95a325899009, createdName=12498dd9m19暂无昵称, createdTime=Thu Aug 17 19:58:00 CST 2017, time=2017-08-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1362667, encodeId=fd29136266ea3, content=<a href='/topic/show?id=707e102e36af' target=_blank style='color:#2F92EE;'>#高血脂#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=102736, encryptionId=707e102e36af, topicName=高血脂)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ced3193, createdName=freve, createdTime=Fri Apr 07 02:58:00 CST 2017, time=2017-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1607357, encodeId=cb2a160e35759, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=121, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Fri Apr 07 02:58:00 CST 2017, time=2017-04-07, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1932037, encodeId=0b4a193203ea1, content=<a href='/topic/show?id=e7bd9e12736' target=_blank style='color:#2F92EE;'>#门诊患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97127, encryptionId=e7bd9e12736, topicName=门诊患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b191324, createdName=marongnuan, createdTime=Tue Jul 04 20:58:00 CST 2017, time=2017-07-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1825829, encodeId=109f182582942, content=<a href='/topic/show?id=c52d388137b' target=_blank style='color:#2F92EE;'>#合并症#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=38813, encryptionId=c52d388137b, topicName=合并症)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=796422, createdName=lvliquan, createdTime=Sun Nov 05 15:58:00 CST 2017, time=2017-11-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1665196, encodeId=2bd9166519644, content=<a href='/topic/show?id=bcb5102e37cf' target=_blank style='color:#2F92EE;'>#高血脂症#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=102737, encryptionId=bcb5102e37cf, topicName=高血脂症)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=95a325899009, createdName=12498dd9m19暂无昵称, createdTime=Thu Aug 17 19:58:00 CST 2017, time=2017-08-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1362667, encodeId=fd29136266ea3, content=<a href='/topic/show?id=707e102e36af' target=_blank style='color:#2F92EE;'>#高血脂#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=102736, encryptionId=707e102e36af, topicName=高血脂)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ced3193, createdName=freve, createdTime=Fri Apr 07 02:58:00 CST 2017, time=2017-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1607357, encodeId=cb2a160e35759, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=121, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Fri Apr 07 02:58:00 CST 2017, time=2017-04-07, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1932037, encodeId=0b4a193203ea1, content=<a href='/topic/show?id=e7bd9e12736' target=_blank style='color:#2F92EE;'>#门诊患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97127, encryptionId=e7bd9e12736, topicName=门诊患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b191324, createdName=marongnuan, createdTime=Tue Jul 04 20:58:00 CST 2017, time=2017-07-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1825829, encodeId=109f182582942, content=<a href='/topic/show?id=c52d388137b' target=_blank style='color:#2F92EE;'>#合并症#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=38813, encryptionId=c52d388137b, topicName=合并症)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=796422, createdName=lvliquan, createdTime=Sun Nov 05 15:58:00 CST 2017, time=2017-11-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1665196, encodeId=2bd9166519644, content=<a href='/topic/show?id=bcb5102e37cf' target=_blank style='color:#2F92EE;'>#高血脂症#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=102737, encryptionId=bcb5102e37cf, topicName=高血脂症)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=95a325899009, createdName=12498dd9m19暂无昵称, createdTime=Thu Aug 17 19:58:00 CST 2017, time=2017-08-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1362667, encodeId=fd29136266ea3, content=<a href='/topic/show?id=707e102e36af' target=_blank style='color:#2F92EE;'>#高血脂#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=102736, encryptionId=707e102e36af, topicName=高血脂)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ced3193, createdName=freve, createdTime=Fri Apr 07 02:58:00 CST 2017, time=2017-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1607357, encodeId=cb2a160e35759, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=121, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Fri Apr 07 02:58:00 CST 2017, time=2017-04-07, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1932037, encodeId=0b4a193203ea1, content=<a href='/topic/show?id=e7bd9e12736' target=_blank style='color:#2F92EE;'>#门诊患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97127, encryptionId=e7bd9e12736, topicName=门诊患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b191324, createdName=marongnuan, createdTime=Tue Jul 04 20:58:00 CST 2017, time=2017-07-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1825829, encodeId=109f182582942, content=<a href='/topic/show?id=c52d388137b' target=_blank style='color:#2F92EE;'>#合并症#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=38813, encryptionId=c52d388137b, topicName=合并症)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=796422, createdName=lvliquan, createdTime=Sun Nov 05 15:58:00 CST 2017, time=2017-11-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1665196, encodeId=2bd9166519644, content=<a href='/topic/show?id=bcb5102e37cf' target=_blank style='color:#2F92EE;'>#高血脂症#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=102737, encryptionId=bcb5102e37cf, topicName=高血脂症)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=95a325899009, createdName=12498dd9m19暂无昵称, createdTime=Thu Aug 17 19:58:00 CST 2017, time=2017-08-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1362667, encodeId=fd29136266ea3, content=<a href='/topic/show?id=707e102e36af' target=_blank style='color:#2F92EE;'>#高血脂#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=102736, encryptionId=707e102e36af, topicName=高血脂)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ced3193, createdName=freve, createdTime=Fri Apr 07 02:58:00 CST 2017, time=2017-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1607357, encodeId=cb2a160e35759, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=121, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Fri Apr 07 02:58:00 CST 2017, time=2017-04-07, status=1, ipAttribution=)]
    2017-04-07 freve
  5. [GetPortalCommentsPageByObjectIdResponse(id=1932037, encodeId=0b4a193203ea1, content=<a href='/topic/show?id=e7bd9e12736' target=_blank style='color:#2F92EE;'>#门诊患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97127, encryptionId=e7bd9e12736, topicName=门诊患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b191324, createdName=marongnuan, createdTime=Tue Jul 04 20:58:00 CST 2017, time=2017-07-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1825829, encodeId=109f182582942, content=<a href='/topic/show?id=c52d388137b' target=_blank style='color:#2F92EE;'>#合并症#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=38813, encryptionId=c52d388137b, topicName=合并症)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=796422, createdName=lvliquan, createdTime=Sun Nov 05 15:58:00 CST 2017, time=2017-11-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1665196, encodeId=2bd9166519644, content=<a href='/topic/show?id=bcb5102e37cf' target=_blank style='color:#2F92EE;'>#高血脂症#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=102737, encryptionId=bcb5102e37cf, topicName=高血脂症)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=95a325899009, createdName=12498dd9m19暂无昵称, createdTime=Thu Aug 17 19:58:00 CST 2017, time=2017-08-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1362667, encodeId=fd29136266ea3, content=<a href='/topic/show?id=707e102e36af' target=_blank style='color:#2F92EE;'>#高血脂#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=102736, encryptionId=707e102e36af, topicName=高血脂)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ced3193, createdName=freve, createdTime=Fri Apr 07 02:58:00 CST 2017, time=2017-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1607357, encodeId=cb2a160e35759, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=121, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Fri Apr 07 02:58:00 CST 2017, time=2017-04-07, status=1, ipAttribution=)]

相关资讯

Hypertension:PM2.5对中国老年人高血压、血压及归因危险的长期影响!

研究结果表明,长期暴露于空气的PM2.5可能是导致高血压发生的重要危险因素,导致了中国成人高血压的负担很大。较高的水果消耗量可能会减轻,而超重和肥胖可以增强这种效应。

内分泌性高血压的3个罪魁祸首!

内分泌性高血压是高血压的一种,其罪魁祸首有哪些呢?

Circulation:γδT细胞介导血管紧张素II诱导的高血压和血管损伤

抗原呈递细胞和适应性免疫T细胞已被报道参与高血压的发展。然而,涉及高血压病理生理学的T淋巴细胞亚群仍不清楚。近期加拿大学者发表研究文章于著名血管期刊Circulation,研究一小部分表达γδT细胞受体(TCR)而不是αβTCR的固有T细胞亚群可能在高血压免疫应答中起作用。本研究目的是确定血管紧张素(Ang)II是否引起γδT细胞的动态变化,γδT细胞缺失阻断Ang II诱导的高血压、血管损伤和T

盘点:预防改善高血压有良方 你知道多少?

本文中,小编整理了多篇研究来阐明如何有效预防和改善高血压症状,分享给各位! 本文中,小编整理了多篇研究来阐明如何有效预防和改善高血压症状,分享给各位! 【1】AJH:女性孕期机体叶酸水平较高或可降低后代患高血压的风险 DOI:10.1093/ajh/hpx003 发表在国际杂志American Journal of Hypertension上的一篇研究报告中,来自国外的研究人员通

盘点:诸如布洛芬等止痛药或会增加个体患心脏病的风险

诸如布洛芬和阿司匹林等药物都属于非甾体类抗炎药物(NSAIDs),其在药店和超市专柜随处可见,但卫生保健提供者有时候却认为这些药物会给人们带来慢性的健康问题,比如肾脏疾病,高血压或者心力衰竭。NSAIDs还会同其它药物发生非常危险的作用,比如一些多种类型的血压和血液稀释药物(华法林和阿司匹林)。

Circ Res:20-HETE影响血管功能、触发高血压

20-羟基二十碳四烯酸(20-HETE)是细胞色素P450类花生酸之一,是一种有效的血管活性脂质,其血管作用包括促进平滑肌细胞收缩,迁移和增殖,并与内皮细胞功能障碍和炎症相关。实验动物和人体中20-HETE水平升高与高血压,中风,心肌梗死和血管疾病等相关。近来来自纽约医科大学的学者发表研究型文章《20-羟基二十碳四烯酸信号通过G蛋白偶联受体GPR75(Gq)影响血管功能、触发高血压》于著名血管杂志